263 related articles for article (PubMed ID: 8636772)
1. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
[TBL] [Abstract][Full Text] [Related]
2. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
[TBL] [Abstract][Full Text] [Related]
3. Second malignancies following treatment in non-Hodgkin's lymphoma.
Ellis M; Lishner M
Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069
[TBL] [Abstract][Full Text] [Related]
4. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
Darrington DL; Vose JM; Anderson JR; Bierman PJ; Bishop MR; Chan WC; Morris ME; Reed EC; Sanger WG; Tarantolo SR
J Clin Oncol; 1994 Dec; 12(12):2527-34. PubMed ID: 7989926
[TBL] [Abstract][Full Text] [Related]
5. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
6. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Metayer C; Curtis RE; Vose J; Sobocinski KA; Horowitz MM; Bhatia S; Fay JW; Freytes CO; Goldstein SC; Herzig RH; Keating A; Miller CB; Nevill TJ; Pecora AL; Rizzo JD; Williams SF; Li CY; Travis LB; Weisdorf DJ
Blood; 2003 Mar; 101(5):2015-23. PubMed ID: 12393427
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Stone RM; Neuberg D; Soiffer R; Takvorian T; Whelan M; Rabinowe SN; Aster JC; Leavitt P; Mauch P; Freedman AS
J Clin Oncol; 1994 Dec; 12(12):2535-42. PubMed ID: 7989927
[TBL] [Abstract][Full Text] [Related]
9. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
10. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.
Armitage JO; Carbone PP; Connors JM; Levine A; Bennett JM; Kroll S
J Clin Oncol; 2003 Mar; 21(5):897-906. PubMed ID: 12610191
[TBL] [Abstract][Full Text] [Related]
11. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
12. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.
Krishnan A; Bhatia S; Slovak ML; Arber DA; Niland JC; Nademanee A; Fung H; Bhatia R; Kashyap A; Molina A; O'Donnell MR; Parker PA; Sniecinski I; Snyder DS; Spielberger R; Stein A; Forman SJ
Blood; 2000 Mar; 95(5):1588-93. PubMed ID: 10688812
[TBL] [Abstract][Full Text] [Related]
13. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
[TBL] [Abstract][Full Text] [Related]
14. Second solid malignancies after combined modality therapy for Hodgkin's disease.
Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
[TBL] [Abstract][Full Text] [Related]
15. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.
Greene MH; Young RC; Merrill JM; DeVita VT
Cancer Res; 1983 Apr; 43(4):1891-8. PubMed ID: 6572558
[TBL] [Abstract][Full Text] [Related]
16. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
Sobecks RM; Le Beau MM; Anastasi J; Williams SF
Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
Kaplan HG; Malmgren JA; Atwood MK
BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
[TBL] [Abstract][Full Text] [Related]
19. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
[TBL] [Abstract][Full Text] [Related]
20. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.
Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Abrahamsen AF; Kvaløy S; Høst H
J Clin Oncol; 1993 Feb; 11(2):255-61. PubMed ID: 8426202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
